Fecal chymotrypsin and elastase-1 determination on one single stool collected at random: diagnostic value for

Isabelle Molinari1, Karamo Souare, Thierry Lamireau

  • 1Biochemistry Laboratory, Hôpital Pellegrin, Bordeaux, France.

Clinical Biochemistry
|August 27, 2004
PubMed

Insights

Measuring fecal proteases from a single stool sample is sufficient for evaluating pancreatic exocrine function. This simplifies testing for pancreatic insufficiency in children, avoiding the need for multiple sample collections.

Area of Science:

  • Pediatric Gastroenterology
  • Diagnostic Testing
  • Pancreatic Function Assessment

Background:

  • The secretin-cholecystokinin test is the gold standard for exocrine pancreatic function but is invasive and costly.
  • Noninvasive tests like fecal chymotrypsin (FChT) and fecal elastase-1 (FEL-1) are alternatives.
  • No established consensus exists for optimal stool collection protocols for these tests.

Purpose of the Study:

  • To determine if collecting stool samples over multiple consecutive days offers a diagnostic advantage compared to a single random sample.
  • To evaluate the diagnostic utility of measuring fecal proteases (chymotrypsin and elastase-1) for pancreatic insufficiency.

Main Methods:

  • 69 children were divided into groups collecting stool for 2 or 3 consecutive days.
  • Fecal chymotrypsin activity and fecal elastase-1 concentration were measured in each stool sample.
  • Patients were categorized as pancreatic-sufficient (PS) or severe pancreatic-insufficient (PI).

Main Results:

  • Significant intraindividual variability was observed for both fecal chymotrypsin and elastase-1.
  • No significant diagnostic discordance was found when comparing 1, 2, or 3 days of stool collection.
  • Variability (CVs) for chymotrypsin was 36% vs. 40.2%, and for elastase-1 was 22.2% vs. 26.8%.

Conclusions:

  • Determining fecal proteases from a single, randomly collected stool sample is adequate for assessing pancreatic exocrine status.
  • This finding simplifies the diagnostic process for pancreatic insufficiency in pediatric patients.
  • A single stool sample is sufficient for evaluating both pancreatic sufficiency and severe insufficiency.
Abstract